Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...

The anifrolumab trial is moving along nicely ... If you were to ask me several years ago, when I started doing clinical trials, and everyone for lupus nephritis failed, I thought, Oh my God ...

but the partners say dapirolizumab pegol achieved a "clinical improvement" in the primary and secondary endpoints, including measures of disease activity and flares. The 321-subject trial is ...

MedImmune will contribute three clinical and three pre-clinical potential new medicines. This includes inebilizumab, currently in phase 2 trials for ... held on to anifrolumab, a late-stage ...

Future research into the heterogeneity of monocytes and macrophages ... and lung biopsies are not necessary for clinical diagnosis and do not substantially contribute to clinical decision-making. This ...

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease.

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...

Discover Skye Bioscience's progress on nimacimab with early trial enrollment, extended treatment protocols, and robust regulatory plans.

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...